"Our mission at Advanced Memory Research Institute of NJ (AMRINJ) is to provide comprehensive care for all people with a concern of memory loss. AMRINJ is at the forefront of clinical research in New Jersey and is a premier clinical trial site. We specialize in identifying memory problems, reviewing currently approved treatment, and clinical research opportunities. Whether you are already being treated for memory loss or just beginning to have concerns, a free consultation is a great step to take for your memory. We offer our services free of charge and will never ask for your insurance information."

During the past decade, Advanced Memory Research Institute of NJ conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 17 clinical trials were completed, i.e. on average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Memory Research Institute of NJ" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Biogen" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Cassava Sciences, Inc." with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Memory Research Institute of NJ" #1 collaborator was "National Institute on Aging (NIA)" with 6 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 2 trials as a collaborator and "Biogen" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Memory Research Institute of NJ" are "Alzheimer's Disease" (22 trials), "Alzheimer Disease" (16 trials), "Dementia" (3 trials), "Central Nervous System Diseases" (2 trials) and "Cognitive Dysfunction" (2 trials). Many other conditions were trialed in "Advanced Memory Research Institute of NJ" in a lesser frequency.

Most popular intervention types in "Advanced Memory Research Institute of NJ" are "Drug" (44 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Aducanumab" (3 trials), "Crenezumab" (3 trials), "Donanemab" (3 trials) and "Lanabecestat" (3 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Memory Research Institute of NJ" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Memory Research Institute of NJ". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Advanced Memory Research Institute of NJ, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Memory Research Institute of NJ, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".